The incidence rate of AKI is increasing across the spectrum of hospitalized children and
adults. Given the increased morbidity and mortality associated with AKI, significant research …

AKI in transplant recipients is a frequent occurrence with significant potential for poor long-
term graft outcomes. Recent efforts to limit ischemia–reperfusion injury and diagnose …

Acute kidney injury (AKI) caused by ischemia–reperfusion is a major clinical problem in both
native and transplanted kidneys. We had previously shown that deficiency of Nrf2, a potent …

The adverse impact of Coronavirus disease 2019 (COVID-19) on kidney function has been
reported since the global pandemic. The burden of COVID-19 on kidney transplant …

Kidney transplantation is the first-choice treatment for end-stage renal disease (ESRD).
Kidney transplant recipients (KTRs) are at higher risk of experiencing a life-threatening …

Acute kidney injury (AKI) is a clinical syndrome with multiple entities. Although AKI implies
renal damage, functional impairment or both, diagnosis is solely based on the functional …

Acute kidney injury (AKI) is a common finding in kidney donors and recipients. AKI in kidney
donor, which increases the risk of delayed graft function (DGF), may not by itself jeopardize …

Acute kidney injury (AKI) in kidney transplant recipients (KTRs) is a common, yet poorly
investigated, complication of urinary tract infections (UTI) and urosepsis. A retrospective …

Kidney transplantation (KT) is an optimal treatment for end-stage renal disease (ESRD).
Currently, short-term KT outcomes are indeed excellent, but long-term successful outcomes …

Post-transplant ischemic acute kidney injury (AKI), secondary to ischemia reperfusion injury
(IRI), is a major problem influencing on the short and long term graft and patient survival …